Alto Neurosciences is halting work on its schizophrenia prospect after the brain-penetrant drug flunked a phase 2 study. The Bay Area biotech evaluated 10 days of treatment with t ...
LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S.NOVA-2 trial to enroll approximately 460 patientsPrimary ...
I remember the first time I heard the time "treatment resistant." It was from a friend as they shared with me their mental health story. As this conversation took place some years before my schooling ...
Huntington Beach, California - March 24, 2026 - PRESSADVANTAGE - Moment of Clarity has released a detailed educational ...
Hosted on MSN
Scientists link immune system proteins to mental health conditions like schizophrenia and depression
New research suggests that immune system activity may play a role in the development of several major mental health conditions. The study, published inMolecular Psychiatry, identified 29 ...
Stressful situations experienced during adolescence tend to cause deeper and more lasting changes to the brain than those ...
Stress in the teen years may have long-term effects on brain function, increasing the risk of mental health disorders later ...
New research bolsters the idea that the risk for psychiatric and developmental disorders isn’t specific to particular conditions — and that could mean new opportunities to treat mental illnesses that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results